A population study to define the incidence and survival of multiple myeloma in a National Health Service Region in UK

British Journal of Haematology

Volumn 127, Issue 3, 2004, Pages 299-304

  Phekoo, K J ^a   Schey, S A ^a   Richards, M A ^b   Bevan, D H ^c   Bell, S ^d   Gillett, D ^e   Moller H ^d  

^a GUY S HOSPITAL   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c ST GEORGE S HOSPITAL   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e Pembury Hospital   (United Kingdom)

Author keywords

Incidence; Multiple myeloma; Population based registry; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE PLANNING; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NATIONAL HEALTH SERVICE; POPULATION RESEARCH; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME; UNITED KINGDOM;

AGE DISTRIBUTION; AGED; ENGLAND; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIPLE MYELOMA; SURVIVAL RATE;

EID: 7944239595     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.05207.x     Document Type: Article

References (18)

1. Altman, D.G. (1991) Practical Statistics for Medical Research. Chapman and Hall, London, UK.
2. Badros, A., Barlogie, B., Siegel, E., Cottler-Fox, M., Zangari, M., Fassas, A., Morris, C., Anaissie, E., Van Rhee, F. & Tricot, G. (2001) Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years. British Journal of Haematology, 114, 600-607.
3. Blade, J., Samson, D., Reece, D., Apperley, J., Bjorkstrand, B., Gahrton, G., Gertz, M., Giralt, S., Jagannath, S. & Vesole, D. (1998) Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high dose therapy and haemopoietic stem cell transplantation. British Journal of Haematology, 102, 1115-1123.
4. Bose, S., Roche, M., Ross, H., Watters, A. & Watts, B. (2002) Haematological Malignancies in the Four Counties, Oxford Cancer Intelligence Unit (Berkshire, Buckinghamshire, Northamptonshire, Oxfordshire). Public Health Resource Unit, Milton Keynes Primary Care Trust, Oxford.
5. Cartwright, R.A. (1999) Time trends in incidence of haematological malignancies and related conditions. British Journal of Haematology, 99, 281-295.
6. Cartwright, R.A., Alexander, F.E., McKinney, P.A. & Ricketts, T.J. (1990) Leukaemia and Lymphoma. An atlas of distribution within areas of England and Wales 1984-1988. Leukaemia Research Fund Centre for Clinical Epidemiology, University of Leeds, Leukaemia Research Fund, Leeds, UK.
7. Cartwright, R.A., Gilman, E.A., Nicholson, P. & Allon, D. (1999) Epidemiology of multiple myeloma in parts of England, 1984. Hematology and Oncology, 17, 31-38.
8. Child, J.A., Morgan, G.J., Davies, F.E., Owen, R.G., Bell, S.E., Hawkins, K., Brown, J., Drayson, M.T. & Selby, P.J. (2003) Medical Research Council Adult Leukaemia Working Party. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. New England Journal of Medicine, 348, 1875-1883.
9. Doll, R. & Smith, P.G. (1967) Summarising indices for comparison of cancer incidence data. International Journal of Cancer, 2, 269-279.
10. Greenlee, R.T., Murray, T., Bolden, S. & Wingo, P.A. (2000) Cancer statistics 2000. CA: A Cancer Journal of Clinicians, 50, 7-33.
11. Hjorth, M., Holmberg, E., Roder, S., Westin, J. & for the Myeloma Group of Western Sweden (1992) Impact of active and passive exclusions on the results of a clinical trial in multiple myeloma. British Journal of Haematology, 80, 55-61.
12. Kyle, R.A., Gertz, M.A., Witzig, T.E., Lust, J.A., Lacy, M.Q., Dispenzieri, A., Fonseca, R., Rajkumar, S.V., Offord, J.R., Larson, D.R., Plevak, M.E., Therneau, T.M. & Greipp, P.R. (2003) Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clinic Proceedings, 78, 21-33.
13. Manoharan, A. (2000) Gentle yet effective treatment for elderly patients with refractory or relapsing multiple myeloma. American Journal of Hematology, 65, 81-82.
14. McNally, R.J. & Cartwright, R.A. (1998) Epidemiology of Multiple Myeloma. Haematolology, 3, 1-15.
15. Ong, F., Hermans, J., Noordijk, E.M., de Kieviet, W., Wijermans, P.W., Seelen, P.J., Snijder, S., Oostindier, M.J. & Kluin-Nelemans, J.C. (1997) Developing a population-based registry for patients with paraproteinemias or multiple myeloma. Journal of Clinical Epidemiology, 50, 909-915.
16. Pollock, A.M. & Vickers, N. (2000) Reducing DCO registrations through electronic matching of cancer registry data and routine hospital data. British Journal of Cancer, 82, 712-717.
17. Powles, R., Raje, N., Milan, S., Millar, B., Shepherd, V., Mehta, J., Singhal, S., Kulkarni, S., Viner, CM, Gore, MM, Cunningham, D. & Treleaven, J. (1997) Outcome assessment of a population-based group of 195 unselected myeloma patients under 70 years of age offered intensive treatment. Bone Marrow Transplantation, 20, 435-443.
18. Westin, E.H. & Longo, D.L. (2004) Lymphoma and myeloma in older patients. Seminars in Oncology, 31, 198-205.